ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,546,469 | -28.3% | 1,054,472 | -13.3% | 0.00% | -33.3% |
| Q2 2023 | $16,095,458 | -18.9% | 1,215,669 | -16.7% | 0.00% | -25.0% |
| Q1 2023 | $19,851,546 | -25.8% | 1,458,600 | +6.4% | 0.00% | -33.3% |
| Q4 2022 | $26,768,345 | +5.5% | 1,370,627 | +2.9% | 0.01% | 0.0% |
| Q3 2022 | $25,374,000 | +66.7% | 1,331,983 | +80.2% | 0.01% | +50.0% |
| Q2 2022 | $15,223,000 | -9.3% | 739,012 | +41.7% | 0.00% | +33.3% |
| Q1 2022 | $16,781,000 | -63.9% | 521,471 | -47.8% | 0.00% | -70.0% |
| Q4 2021 | $46,510,000 | +76.6% | 998,941 | +2.4% | 0.01% | +100.0% |
| Q3 2021 | $26,336,000 | +3.3% | 975,418 | -1.9% | 0.01% | -16.7% |
| Q2 2021 | $25,506,000 | +46.0% | 994,396 | +94.6% | 0.01% | +50.0% |
| Q1 2021 | $17,466,000 | -35.2% | 510,998 | -35.9% | 0.00% | -42.9% |
| Q4 2020 | $26,965,000 | +21.7% | 797,314 | -11.2% | 0.01% | +16.7% |
| Q3 2020 | $22,161,000 | – | 898,289 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |